作为过敏性喘中新型治疗点的CXCR6
Nanting Zou1, Xiaodong Yan1, Zhao Wu2
1First Clinical Medical College, School of Chinese Materia Medica and School of BasicMedical Sciences,Yunnan University of Chinese Medicine, Kunming 650021, China.
International immunopharmacology
|December 11, 2025
概括
在致病性CD4+T细胞上准C-X-C基因化学因受体6 (CXCR6) 是对过敏性喘的一个有希望的策略. 在小鼠模型中,耗尽CXCR6+细胞减少了肺炎和关键细胞因子的产生.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
背景情况:
- C-X-C 基因化学因子受体6 (CXCR6) 是炎症性疾病中致病性 CD4+ T 细胞的标记物.
- 它在CD4+T细胞和过敏喘病原体中的作用尚不清楚.
- 研究CXCR6作为过敏性喘的治疗点至关重要.
研究的目的:
- 研究CXCR6在过敏性喘中CD4+T细胞中的作用.
- 评估CXCR6作为过敏性喘的潜在治疗标.
主要方法:
- 建立了一个卵胺 (OVA) 诱导的过敏喘小鼠模型.
- 使用多参数流细胞计,RT-qPCR和西式涂抹来分析CXCR6的表达.
- 孤立的CXCR6+CD4+和CXCR6-CD4+T细胞用于RNA测序.
- 用于消耗CXCR6+细胞和评估治疗效果的抗CXCR6抗体.
主要成果:
- 在喘小鼠肺部中,CXCR6+CD4+T细胞被丰富,产生IL-17和IFN-γ.
- 在Th1和Th17细胞中CXCR6表达升高,但在Th2或Treg细胞中没有.
- 反CXCR6抗体治疗减少了气道炎症,粘液,IgE和关键细胞因子水平,包括IL-17,IFN-γ,IL-4和IL-13.
结论:
- 在喘小鼠的肺部,CXCR6+CD4+T细胞显著丰富,与炎症有关.
- 向CXCR6是一种有前途的免疫治疗方法,用于过敏性喘.
更多相关视频
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
01:30Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
01:24Antiasthma Drugs: Methylxanthines
1.5K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.5K
01:26Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K